首页/数据集/Trial characteristics: A. Paniculata plus usual care versus Usual care (n = 9).

Trial characteristics: A. Paniculata plus usual care versus Usual care (n = 9).

Figshare2017-08-05 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Trial_characteristics_i_A_i_i_Paniculata_i_plus_usual_care_versus_Usual_care_n_9_/5279503 数据链接链接失效反馈

官方服务：

资源简介：

Trial characteristics: A. Paniculata plus usual care versus Usual care (n = 9).

应用场景：

创建时间：

2017-08-05

药物临床试验

数据透明性

August 19, 2014. 6:00AM (Bogotá time zone) Third request of retraction: NEJM, Boehringer, Pradaxa, dabigatran, RE-LY study. (1st URL attached below). <strong

DataCite Commons2020-09-04 更新40

Baseline characteristics of hypertensive patients eligible to receive single-pill combination indapamide SR/amlodipine 1.5 mg/5 mg.

药物临床试验

心血管代谢疾病

Values are means±standard deviation. All other values are numbers and percentages. CCB, calcium channel blocker; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-den

Figshare2015-12-02 更新10

Phase 2b study of S-888711 in thrombocytopenic patients with chronic liver disease

药物临床试验

血小板减少症治疗

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promot

DataCite Commons2024-12-02 更新00

Ticagrelor database | WHO ICTRP, ClinicalTrials.gov, Embase, PubMed, ISI, others

药物临床试验

循证医学

Database in progress This database complies with the terms and conditions of ClinicalTrials.gov (available at:http://clinicaltrials.gov/ct2/about-site/terms-conditions) and the WHO ICTRP (available at

Figshare2016-01-19 更新10

Dataset from A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

前列腺癌治疗

药物临床试验

The purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.

NIAID Data Ecosystem00

Trial characteristics: A. Paniculata plus usual care versus Usual care (n = 9).

资源简介：

相关数据集